Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea

Mostrar otras versiones (1)

BACKGROUND: Cervical cancer is a prevalent malignancy that is a major health problem for women worldwide. The cancer-preventive properties of metformin are well-known, but insufficient data have been reported regarding its relationship to cervical cancer. Therefore, in a nationwide population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun Min, Kang, Min Jin, Song, Sun Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816509/
https://www.ncbi.nlm.nih.gov/pubmed/36604960
http://dx.doi.org/10.3803/EnM.2022.1613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816509/
https://www.ncbi.nlm.nih.gov/pubmed/36604960
http://dx.doi.org/10.3803/EnM.2022.1613

Ejemplares similares